glucagon has been researched along with Bright Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
Dziedzic, TS; Smith, TP | 1 |
al-Bander, H; Hutchison, FN; Jones, H; Kaysen, GA; Martin, VI | 1 |
Kazakova, IA; Nasachev, AA; Trusov, VV | 1 |
Davis, BB; Josimovich, JB; Mintz, DH; Pawlson, LG; Taylor, AL | 1 |
Bilbrey, GL; Faloona, GR; Knochel, JP; White, MG | 1 |
6 other study(ies) available for glucagon and Bright Disease
Article | Year |
---|---|
Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Glucagon; Glucose Transporter Type 1; Glycated Hemoglobin; Glycogen; Hypertension; Kidney; Male; Norepinephrine; Proteinuria; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2013 |
Glucagon-induced vasospasm of hepatic artery branches during visceral angiography.
Topics: Aged; Angiography; Biopsy; Contrast Media; Diagnosis, Differential; Glomerulonephritis; Glucagon; Hepatic Artery; Humans; Iopamidol; Male; Spasm | 2008 |
Branched-chain amino acids augment neither albuminuria nor albumin synthesis in nephrotic rats.
Topics: Albuminuria; Amino Acids; Amino Acids, Branched-Chain; Animals; Dietary Proteins; Glomerulonephritis; Glucagon; Male; Nephrotic Syndrome; Rats; Rats, Inbred Strains; Serum Albumin | 1991 |
[Characteristics of carbohydrate metabolic disorders and of the secretion of insulin, glucagon and somatotropin in patients with chronic glomerulonephritis and chronic kidney failure].
Topics: Adolescent; Adult; Blood Glucose; Carbohydrate Metabolism; Chronic Disease; Female; Glomerulonephritis; Glucagon; Growth Hormone; Humans; Insulin; Insulin Antibodies; Insulin Secretion; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 1986 |
Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans.
Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Chronic Disease; Circadian Rhythm; Creatinine; Cyclic AMP; Female; Glomerulonephritis; Glucagon; Growth Hormone; Humans; Hyperparathyroidism; Hypoparathyroidism; Male; Menstruation; Middle Aged; Osmolar Concentration; Parathyroid Hormone; Phosphates; Pregnancy; Pyelonephritis; Tritium; Urine; Vasopressins | 1970 |
Hyperglucagonemia of renal failure.
Topics: Adult; Animals; Antigens; Blood Glucose; Blood Urea Nitrogen; Carbohydrate Metabolism; Creatinine; Dietary Proteins; Dogs; Fasting; Glomerulonephritis; Glucagon; Glucose; Humans; Infusions, Parenteral; Insulin; Kidney Failure, Chronic; Middle Aged; Nephrosclerosis; Polycystic Kidney Diseases; Potassium; Renal Dialysis; Serum Albumin; Uremia | 1974 |